Cargando…

NICE COVID-19 rapid guidelines

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	News Item
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085796/ https://www.ncbi.nlm.nih.gov/pubmed/33948079 http://dx.doi.org/10.1007/s40274-021-7682-3

Ejemplares similares

NICE to publish guidelines for rare blood clotting syndrome from COVID-19 vaccination
Publicado: (2021)

NICE recommends acalabrutinib for chronic lymphocytic leukaemia
Publicado: (2021)

NICE consulting on methods used for health technology evaluation
Publicado: (2020)

NICE guideline on long COVID
por: Venkatesan, Priya
Publicado: (2021)

FDA reports recall of Innova COVID-19 antigen rapid qualitative test
Publicado: (2021)

Health Canada: risk of accidental poisoning from COVID-19 rapid antigen test kits
Publicado: (2022)

COVID-19 vaccine safety monitoring
Publicado: (2021)

COVID-19 vaccination encouraged by the EMA/ECDC
Publicado: (2021)

Cutaneous vasculitis following COVID-19 vaccination
Publicado: (2021)

Myocarditis, pericarditis with COVID-19 vaccines in the Netherlands
Publicado: (2021)

Myocarditis or pericarditis following COVID-19 vaccination
Publicado: (2021)

Myocarditis and pericarditis after COVID-19 vaccination
Publicado: (2021)

HTA assessment of COVID-19 interventions in Ireland
Publicado: (2020)

Risks of chloroquine or hydroxychloroquine use for COVID-19
Publicado: (2020)

COVID-19 vaccination and risk of neuralgic amyotrophy
Publicado: (2022)

ISMP reports: errors or hazards with COVID-19 vaccines
Publicado: (2021)

Advice on COVID-19 vaccines approved in UK by MHRA
Publicado: (2021)

Second HPRA safety update on COVID-19 vaccines
Publicado: (2021)

AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021)

Falsified COVID-19 vaccine recently identified in Mexico
Publicado: (2021)

Health Canada: AKI or ARF with remdesivir for COVID-19?
Publicado: (2021)

Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Warnings of risks associated with ivermectin use for COVID-19
Publicado: (2021)

Product monographs for COVID-19 vaccines updated in Canada
Publicado: (2021)

No association between COVID-19 vaccination and menstrual disorders
Publicado: (2021)

Janssen COVID-19 vaccine-related tinnitus and dizziness
Publicado: (2021)

EMA assessing safety of anakinra in adults with COVID-19
Publicado: (2021)

PMDA: precautions should be revised for Covid-19 vaccine
Publicado: (2021)

COVID-19 vaccine and influenza vaccine mix-ups
Publicado: (2021)

Possibility of mix-up with paediatric COVID-19 vaccines
Publicado: (2021)

PRAC: blood clots with Janssen's COVID-19 vaccine
Publicado: (2021)

COVID-19 vaccination errors in USA reported to ISMP
Publicado: (2021)

Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

COVID-19 pregnancy prevention guidance on teratogenic drugs
Publicado: (2020)

EMA's safety monitoring plan for COVID-19 vaccines
Publicado: (2020)

ICER update to pricing models of remdesivir for COVID-19
Publicado: (2020)

ICER's timelines for assessments extended due to COVID-19
Publicado: (2020)

Evaluation of potential therapies for COVID-19 global pandemic
Publicado: (2020)

MHRA COVID-19 website for reporting ADRs and incidents
Publicado: (2020)

Signal for COVID-19 vaccine-related menstrual disorders
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rugl5sf3src295qnveo9ilql1u